NewsBite

Stockhead

More Stories

Stockhead
NUZ 1024x678 (1)

Break it Down: Neurizon

Neurizon Therapeutics continues to make strides on its NUZ-001 treatment for ALS, paving the way for next stage clinical trials.

Original URL: https://www.couriermail.com.au/business/stockhead/page/181